Strategic Partnerships Clarion is part of Lumanity, a broader network with recent AI and healthcare strategy partnerships (for example with Sorcero) that open cross-sell opportunities for AI-enabled strategic services and life sciences market access projects.

Life Sciences Focus With a Gold rating in Pharma & Life Sciences and a history of partnerships with pharmaco-economic and drug outcomes research groups, target biopharma and medtech clients looking for commercialization, lifecycle, and market access expertise.

Acquisition Momentum The acquisition of Clarion in 2022 signals integrated capabilities and expanded US life sciences consulting, suggesting opportunities to upsell end-to-end product lifecycle solutions and broader strategic engagements.

Digital Tools Adoption of modern collaboration and information management tools (Microsoft SharePoint, Google Workspace, XML, PHP) indicates readiness to implement scalable, tech-enabled strategy programs for large clients and internal process efficiencies.

Growth Enablement Recent launches like Lumanity Pathway demonstrate productized offerings to map patient lived experience, presenting a pathway to package and sell patient-centric strategy and market access services to life sciences clients.